Sort
30,917 grants matching “tumor microenvironment”
Proj 3 - Targeting the Pro-tumorigenic Microenvironment
$555,724Yves A Declerck · Children'S Hosp Of Philadelphia · P01 · FY2021 · CA
The role of the female and male reproductive microenvironment in fertility fitness
$555,722Christina Farr Zuend · Case Western Reserve University · R01 · FY2023 · HD
Cell density effects on therapeutic sensitivity
$555,645Jayne Stommel · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
$555,585A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Simultaneous Microwave and MR Imaging for Improved Diagnosis of Breast Abnormalities
$555,556Keith D. Paulsen · Dartmouth College · R01 · FY2024 · CA
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$555,474Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2025 · CA
Regulation of memory T cell differentiation and long-term maintenance
$555,289Ananda W Goldrath · University Of Florida · P01 · FY2023 · AI
Effects of chronic pubertal stressors on mammary gland biology and cancer risk
$555,187Matthew J Brady · University Of Chicago · R01 · FY2022 · CA
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$555,175Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Prostate Section
$555,067Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Role of circular RNA CDR1as in melanoma
$554,989Eva Hernando · New York University School Of Medicine · R01 · FY2022 · CA
Repurposing TRM for tumor immunotherapy
$554,986David Masopust · University Of Minnesota · R01 · FY2021 · CA
Chemotherapy and the Bladder Cancer Immune Microenvironment
$554,816William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Chemotherapy and the Bladder Cancer Immune Microenvironment
$554,812William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
$554,758Mary L. Disis · University Of Washington · R01 · FY2013 · CA
Photon-counting X-ray and Optical Tomography for Preclinical Cancer Research
$554,732Ge Wang · Rensselaer Polytechnic Institute · R01 · FY2020 · CA
New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
$554,729Jianguo Tao · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
$554,729John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Surrogate biomarkers for assessing changes in pancreatic cancer tumor microenvironment
$554,438Marvin M Doyley · University Of Rochester · R01 · FY2024 · EB
UNDERSTANDING STROMAL FIBROBLAST HETEROGENEITY IN THE PANCREATIC TUMOR MICROENVIRONMENT
$554,400Oregon Health & Science University · · FY2018 · Department of the Army
Development of antibacterial agents and materials
$554,371Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
MRI and blood biomarkers of neoadjuvant therapy response and outcomes in rectal cancer
$554,345Ruijiang Li · Stanford University · R01 · FY2024 · CA
âPharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment responseâ
$554,314Robert C Rostomily · Methodist Hospital Research Institute · R01 · FY2025 · NS
Data Processing, Analysis and Modeling Unit
$554,259Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2020 · CA
DEFINING THE DORMANT TUMOR MICROENVIRONMENT FOR BREAST CANCER PREVENTION AND TREATMENT
$554,209The Regents Of The University Of Colorado · · FY2010 · Department of Defense